Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Cyclophosphamide and Interferon-alpha in Neuroendocrine Tumors
NCT02838342Phase 2Completed
- Sponsor
- CHU de Besançon
- Start
- May 2015
- Primary completion
- Apr 2020
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, interferon alfa in neuroendocrine tumors (NETs), sponsored by CHU de Besançon. Started May 2015; status: completed.
02
Drugs
cyclophosphamideinterferon alfa
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT02838342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838342.